Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Senior Writer
Surgeons and obesity-medicine doctors increasingly combine bariatric procedures with GLP-1s, before or after surgery. We compare percent total weight loss, durability, costs, and who benefits from each path.
Most GLP-1 prescriptions ship with a pen and a leaflet but limited coaching. Here is a plain-language walkthrough of injection sites, rotation, and the mistakes that cause bruising.
The FDA officially resolved the GLP-1 shortage in 2025, but regional availability still varies. Here is the current FDA shortage list status and what pharmacists report on the ground in 2026.
Microdosing semaglutide has exploded on Reddit and TikTok as a tolerability and cost hack. We cover what off-label means here, pharmacokinetic concerns, and questions to bring to your prescriber.
GLP-1 medications cut appetite so dramatically that plant-based eaters routinely fall short on protein. Here is how to hit 1.2-1.6 g/kg with tofu, tempeh, seitan, and legumes when nothing sounds good.
GLP-1 medications have specific contraception and pregnancy planning requirements most prescribers rush through. We cover the Wegovy washout, Mounjaro's oral contraceptive warning, and breastfeeding gaps.
Most GLP-1 side effects follow a predictable arc tied to dose escalation. Here is what patients commonly report each week and when symptoms typically peak.
Hair shedding is one of the most-searched GLP-1 side effects, but it is rarely caused by the drug itself. Here is the mechanism, the timeline, and what dermatologists tell patients.
Sulfur burps are one of the most viral GLP-1 complaints on TikTok and Reddit. Here is the digestive mechanism behind the rotten-egg smell, why delayed gastric emptying makes it worse, and the dietary patterns associated with relief.
Savings cards advertise $25 monthly prices, but eligibility carve-outs exclude most patients. Here is what each manufacturer card actually covers in 2026.
After the FDA shortage ended, branded self-pay prices dropped while compounded options narrowed. Here is the cost math between LillyDirect, NovoCare, and remaining compounded routes.
Tirzepatide and semaglutide are the two dominant GLP-1 classes but work differently. Here is what SURMOUNT, STEP, and SURPASS data show about efficacy and tolerability.
Mounjaro and Zepbound contain identical tirzepatide but are FDA-approved for different conditions. Here is what that means for insurance, pricing, and prescriber decisions.
Saxenda was the original GLP-1 weight-loss injection but Wegovy replaced it for most patients. Here is when liraglutide may still be the right molecule and how the two compare on trial data.
Both Ozempic and Wegovy are semaglutide, but FDA-approved for different conditions. Here is exactly how to switch — clinically, administratively, and practically.
Wegovy retails near $1,349/month without insurance. But several legitimate channels reduce the cost to $200-400/month. Here is a complete breakdown of your options in 2026.
In March 2026, the FDA sent warning letters to dozens of telehealth providers marketing compounded GLP-1 medications. This explainer covers what changed, why, and what your options are now.
"Ozempic face" refers to facial volume loss seen in some patients during GLP-1 weight loss. It is not a side effect of the drug itself, but a consequence of rapid fat loss. Here is what to know.
Clinical trial data shows where you are likely to be at each stage of GLP-1 weight loss treatment. Here is a month-by-month timeline of realistic expectations.